Scholars@Duke publication: Disrupting the Management of Calcified Femoropopliteal Peripheral Artery Disease: Mid-term Outcomes From Disrupt PAD III

Disrupting the Management of Calcified Femoropopliteal Peripheral Artery Disease: Mid-term Outcomes From Disrupt PAD III

Publication , Journal Article

Rymer, JA; Armstrong, E; Secemsky, EA

Published in: Journal of the Society for Cardiovascular Angiography and Interventions

July 1, 2022

Journal of the Society for Cardiovascular Angiography and Interventions

2772-9303

July 1, 2022

APA

Chicago

ICMJE

MLA

NLM

Rymer, J. A., Armstrong, E., & Secemsky, E. A. (2022). Disrupting the Management of Calcified Femoropopliteal Peripheral Artery Disease: Mid-term Outcomes From Disrupt PAD III. Journal of the Society for Cardiovascular Angiography and Interventions, 1(4). https://doi.org/10.1016/j.jscai.2022.100369

Rymer, J. A., E. Armstrong, and E. A. Secemsky. “Disrupting the Management of Calcified Femoropopliteal Peripheral Artery Disease: Mid-term Outcomes From Disrupt PAD III.” Journal of the Society for Cardiovascular Angiography and Interventions 1, no. 4 (July 1, 2022). https://doi.org/10.1016/j.jscai.2022.100369.

Rymer JA, Armstrong E, Secemsky EA. Disrupting the Management of Calcified Femoropopliteal Peripheral Artery Disease: Mid-term Outcomes From Disrupt PAD III. Journal of the Society for Cardiovascular Angiography and Interventions. 2022 Jul 1;1(4).

Rymer, J. A., et al. “Disrupting the Management of Calcified Femoropopliteal Peripheral Artery Disease: Mid-term Outcomes From Disrupt PAD III.” Journal of the Society for Cardiovascular Angiography and Interventions, vol. 1, no. 4, July 2022. Scopus, doi:10.1016/j.jscai.2022.100369.

Journal of the Society for Cardiovascular Angiography and Interventions

2772-9303

July 1, 2022